Professional development Vacancies

Lasolvan® (ambroxol)

13.10.2013 Updated 22.10.2019 4382 views

By MoH of Ukraine order No. 860 of 04.10.13, the instructions for medical use (hereinafter – the instructions) of the original (reference) medicinal product containing ambroxol, namely the product Lasolvan®, tablets, were approved with amendments and additions to the section of the instructions: “Contraindications”, “Appropriate safety precautions for use”, “Adverse reactions”, “Use during pregnancy or breastfeeding”, “Ability to influence reaction time when driving or operating other machinery”, “Children”, “Overdose”, “Interaction with other medicinal products and other forms of interaction”.

List of medicinal products containing ambroxol as an ingredient that are authorized for medical use in Ukraine.